Skip to main content

Select Drug Profiles

Practice Management
Clinical Decision Support Helps Compliance with Evidence-Based Pathways
Chase Doyle
Chase Doyle
Read More
Practice Management
Cemiplimab Cost-Effective for Advanced Cutaneous Squamous-Cell Carcinoma
Chase Doyle
Chase Doyle
Read More
Practice Management
Germline Alterations Analysis Has Actionable Value in Selecting Targetable Treatments for Patients with Advanced Cancer
Chase Doyle
Chase Doyle
Read More
Practice Management
The Value of Some Cancer Drugs Changes Substantially After Their Approval
Chase Doyle
Read More
Lung Cancer, Oncology
Durvalumab plus Chemotherapy New Standard of Care for Extensive-Stage Small-Cell Lung Cancer
Phoebe Starr
Phoebe Starr
Read More
Lung Cancer, Oncology
Capmatinib Shows Activity in MET-Amplified Non–Small-Cell Lung Cancer
Wayne Kuznar
Wayne Kuznar
Read More
FDA Approvals
Tumor-Infiltrating Lymphocyte Therapy Induces Responses Across Wide Range of Patients with Advanced Melanoma
Wayne Kuznar
Wayne Kuznar
Read More
FDA Approvals
The WEE1 Inhibitor Adavosertib Displays Promising Clinical Activity in Uterine Serous Cancer
Wayne Kuznar
Wayne Kuznar
Read More
FDA Approvals
Intratumoral Injection of Cisplatin and Vinblastine, with or without Pembrolizumab, Improves Intracellular Transport in Patients with Advanced Solid Tumors
Chase Doyle
Chase Doyle
Read More
Adjuvant Atezolizumab Did Not Show Disease-Free Survival Benefit in High-Risk Urothelial Cancer
Phoebe Starr
Phoebe Starr
Read More
Page 33 of 244
Results 321 - 330 of 2438